Anticoagulant protein S-New insights on interactions and functions

Magdalena Gierula1, Josefin Ahnström1

  • 1Centre for Haematology, Imperial College London, London, UK.

Insights

Protein S is a vital regulator of blood clotting, acting as a cofactor and directly inhibiting clot formation. Understanding its complex mechanisms is key to addressing thrombosis risks associated with protein S deficiency.

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Protein S is an essential regulator of hemostasis, serving as a cofactor for activated protein C (APC) and tissue factor pathway inhibitor (TFPI).
  • It possesses direct anticoagulant functions, inhibiting key complexes in the coagulation cascade, thus regulating both initiation and propagation phases.
  • Protein S deficiency is strongly linked to an increased risk of venous thrombosis, highlighting its critical role in preventing excessive clotting.

Purpose of the Study:

  • To provide an updated review of protein S functions in hemostatic regulation.
  • To elucidate the molecular mechanisms underlying protein S cofactor activities.
  • To highlight recent advances in understanding protein S's role in coagulation.

Main Methods:

  • Review of existing literature and recent research findings on protein S.
  • Analysis of molecular mechanisms and cofactor functions.
  • Examination of the role of synergistic cofactors and phospholipid binding.

Main Results:

  • Protein S regulates coagulation through cofactor roles and direct inhibition of enzymatic complexes.
  • Its anticoagulant properties are often enhanced by synergistic cofactors and formation of complexes on phospholipid surfaces.
  • High-affinity binding to phospholipids facilitates targeted regulation of coagulation.

Conclusions:

  • Protein S is indispensable for effective hemostatic regulation, acting via multiple pathways.
  • Recent findings reveal the importance of cofactor synergy and phospholipid interactions in protein S function.
  • Further clarification of molecular mechanisms will advance our understanding of thrombosis and anticoagulation.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
466
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.8K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
370
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.5K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
427